AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11522552 — intervention group
Group type: COMPARATOR
Intervention: 4 cups of coffee (700 mL/d) for 6 weeks
Number of subjects: 191
Study 9296422 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol 1 microg
Number of subjects: 45
Study 9296422 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol 2 microg
Number of subjects: 45
Study 9296422 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol 3 microg
Number of subjects: 45
Study 9296422 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol (all doses)
Number of subjects: 45
Study 9296422 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol (3 microg)
Number of subjects: 45
Study 8299597 — intervention group
Group type: EXPERIMENTAL
Intervention: High CHO diet (83% of energy intake as CHO)
Number of subjects: 14
Study 8299597 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate CHO diet (58% of energy intake as CHO)
Number of subjects: 14
Study 8299597 — intervention group
Group type: COMPARATOR
Intervention: Low CHO diet (12% of energy intake as CHO)
Number of subjects: 14
Study 30777508 — intervention group
Group type: EXPERIMENTAL
Intervention: Cantonese-accented words presented auditorily
Number of subjects: 0
Study 30777508 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory presentation of accented words
Number of subjects: 0
Study 30777508 — intervention group
Group type: EXPERIMENTAL
Intervention: Lengthened interstimulus intervals in accented word recall (Experiment 2)
Number of subjects: 0
Study 27792212 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 639
Study 27792212 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (EA)
Number of subjects: 639
Study 27792212 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block (FNB)
Number of subjects: 639
Study 27792212 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block with dexamethasone (FNB+Dexa)
Number of subjects: 639
Study 27792212 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block with dexmedetomidine (FNB+Dexm)
Number of subjects: 639
Study 27792212 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block (ACB)
Number of subjects: 639
Study 27792212 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block with dexamethasone (ACB+Dexa)
Number of subjects: 639
Study 27792212 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block with dexmedetomidine (ACB+Dexm)
Number of subjects: 639
Study 27792212 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 639
Study 26897374 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Electric Field (PEF) treatment at 15 kV/cm and 100 mL/min flow velocity
Number of subjects: 0
Study 26897374 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Electric Field (PEF) treatment
Number of subjects: 0
Study 26897374 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated α-amylase)
Number of subjects: 0
Study 25052847 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (25 mg)
Number of subjects: 63
Study 25052847 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg)
Number of subjects: 63
Study 25052847 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg) + Amitriptyline (25 mg)
Number of subjects: 63
Study 25052847 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin + Amitriptyline
Number of subjects: 63
Study 25052847 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 63
Study 25052847 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 63
Study 22033534 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (LHTL group, n = 10)
Number of subjects: 16
Study 22033534 — intervention group
Group type: COMPARATOR
Intervention: Normal air (placebo group, n = 6)
Number of subjects: 16
Study 19535710 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 40
Study 19535710 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study 19535710 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 40
Study 17659464 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIC (mitomycin C 30 mg and cisplatin 100 mg in 2000 ml distilled water, heated to 42-45 degrees C, perfused for 30 min) and intravenous chemotherapy (5-FU 10-15 mg/kg, mitomycin C 0.1-0.15 mg/kg, adriamycin 0.5-1 mg/kg i.v drip, once a week for 2-3 weeks)
Number of subjects: 212
Study 17659464 — intervention group
Group type: COMPARATOR
Intervention: Intravenous chemotherapy only (control group)
Number of subjects: 212
Study 17659464 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIC
Number of subjects: 212
Study 15219642 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary insomnia patients
Number of subjects: 29
Study 15219642 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 29
Study 10708177 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin
Number of subjects: 32
Study 10708177 — intervention group
Group type: COMPARATOR
Intervention: Dalteparin
Number of subjects: 32
Study 10708177 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin and Dalteparin
Number of subjects: 32
Study 9236673 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 therapy (1 mg/kg)
Number of subjects: 0
Study 9236673 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 therapy (10 mg/kg)
Number of subjects: 0
Study 9236673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9236673 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 therapy (1 mg/kg and 10 mg/kg)
Number of subjects: 0
Study 9236673 — intervention group
Group type: EXPERIMENTAL
Intervention: cA2 therapy
Number of subjects: 0
Study 8370794 — intervention group
Group type: EXPERIMENTAL
Intervention: Women-only group
Number of subjects: 57
Study 8370794 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples-only group
Number of subjects: 57
Study 8370794 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 57
Study 3531924 — intervention group
Group type: EXPERIMENTAL
Intervention: O‐(beta‐hydroxyethyl)‐rutosides (4 g/day orally)
Number of subjects: 40
Study 3531924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31736356 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Expanding Transcatheter Heart Valve (SE-THV)
Number of subjects: 3910
Study 31736356 — intervention group
Group type: COMPARATOR
Intervention: Balloon-Expandable Transcatheter Heart Valve (BE-THV)
Number of subjects: 3910
Study 28891824 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP (LFOD) diet
Number of subjects: 11
Study 28891824 — intervention group
Group type: COMPARATOR
Intervention: High FODMAP (HFOD) diet
Number of subjects: 11
Study 28477684 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline history of falls
Number of subjects: 1741
Study 28477684 — intervention group
Group type: COMPARATOR
Intervention: Men vs Women
Number of subjects: 1741
Study 28477684 — intervention group
Group type: EXPERIMENTAL
Intervention: UPDRS Activities of Daily Living (ADL) score
Number of subjects: 1741
Study 28477684 — intervention group
Group type: EXPERIMENTAL
Intervention: Total functional capacity (TFC)
Number of subjects: 1741
Study 28477684 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ambulatory capacity score
Number of subjects: 1741
Study 28477684 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine agonist monotherapy
Number of subjects: 1741
Study 26362000 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 151
Study 23444107 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent capture during attentional blink
Number of subjects: 0
Study 23444107 — intervention group
Group type: COMPARATOR
Intervention: Concurrent task demands
Number of subjects: 0
Study 21382512 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% C31G or SAVVY®
Number of subjects: 7086
Study 21382512 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% cellulose sulfate or CS
Number of subjects: 7086
Study 21382512 — intervention group
Group type: COMPARATOR
Intervention: Baseline factors associated with non-retention
Number of subjects: 7086
Study 18996868 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein supplement (40 g whey protein, 280 kcal, twice daily for 12 weeks)
Number of subjects: 59
Study 18996868 — intervention group
Group type: COMPARATOR
Intervention: Control supplement (matched isocaloric supplement without added protein, twice daily for 12 weeks)
Number of subjects: 59
Study 16842920 — intervention group
Group type: EXPERIMENTAL
Intervention: Bradykinin
Number of subjects: 29
Study 16842920 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine
Number of subjects: 29
Study 16842920 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance P
Number of subjects: 29
Study 16842920 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin
Number of subjects: 29
Study 16842920 — intervention group
Group type: COMPARATOR
Intervention: Antihistamine (olopatadine hydrochloride)
Number of subjects: 29
Study 12671528 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg daily in addition to perphenazine (8 mg/day or 16 mg/day)
Number of subjects: 12
Study 12671528 — intervention group
Group type: COMPARATOR
Intervention: Perphenazine (8 mg/day or 16 mg/day)
Number of subjects: 12
Study 10902982 — intervention group
Group type: EXPERIMENTAL
Intervention: Condensed milk + micronutrients
Number of subjects: 156
Study 10902982 — intervention group
Group type: EXPERIMENTAL
Intervention: Skimmed milk + micronutrients
Number of subjects: 156
Study 10902982 — intervention group
Group type: EXPERIMENTAL
Intervention: Skimmed milk
Number of subjects: 156
Study 9373659 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% paromomycin (aminosidine) and 10% urea in white paraffin
Number of subjects: 53
Study 9373659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 1542491 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous 5-fluorouracil (5-FU) at a dose of 650 mg/m2 per day for 7 consecutive days, escalated in subsequent cycles
Number of subjects: 38
Study 1542491 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous 5-fluorouracil (5-FU)
Number of subjects: 38
Study 31221565 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nepafenac 0.3%
Number of subjects: 60
Study 31221565 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure patching for 2 hours
Number of subjects: 60
Study 31221565 — intervention group
Group type: COMPARATOR
Intervention: Preservative-free artificial tears (control group)
Number of subjects: 60
Study 28045585 — intervention group
Group type: EXPERIMENTAL
Intervention: Zagreb regimen
Number of subjects: 114
Study 28045585 — intervention group
Group type: COMPARATOR
Intervention: Essen regimen
Number of subjects: 114
Study 27561822 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-enhanced telephone health coaching intervention (IGR3)
Number of subjects: 0
Study 27561822 — intervention group
Group type: COMPARATOR
Intervention: Telephone-only health coaching intervention (IGR2)
Number of subjects: 0
Study 24939313 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention (mailing knowledge manual, face-to-face counseling, telephone counseling)
Number of subjects: 771
Study 24939313 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods (control group)
Number of subjects: 771
Study 24939313 — intervention group
Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 771
Study 22435986 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction using Flippits® cards
Number of subjects: 123
Study 22435986 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 123
Study 19050620 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoxygenation for 4 mins with 100% oxygen
Number of subjects: 34
Study 19050620 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoxygenation for 6 mins with 100% oxygen
Number of subjects: 34
Study 19050620 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoxygenation for 8 mins with 100% oxygen
Number of subjects: 34
Study 18444818 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (7vPnC)
Number of subjects: 0
Study 18444818 — intervention group
Group type: EXPERIMENTAL
Intervention: 7vPnC/7vPnC
Number of subjects: 0
Study 18444818 — intervention group
Group type: EXPERIMENTAL
Intervention: 7vPnC/PPV
Number of subjects: 0
Study 18444818 — intervention group
Group type: COMPARATOR
Intervention: PPV/7vPnC
Number of subjects: 0
Study 16196295 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral diet supplemented with glutamine, arginine and omega‐3‐fatty acid
Number of subjects: 40
Study 16196295 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral nutrition
Number of subjects: 40
Study 12537922 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine service
Number of subjects: 74
Study 12537922 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 74
Study 10418768 — intervention group
Group type: EXPERIMENTAL
Intervention: Calloused sexual beliefs (CSB)
Number of subjects: 100
Study 10418768 — intervention group
Group type: COMPARATOR
Intervention: Noncoercive men
Number of subjects: 100
Study 10418768 — intervention group
Group type: EXPERIMENTAL
Intervention: Coercive men low in CSB
Number of subjects: 100
Study 10418768 — intervention group
Group type: COMPARATOR
Intervention: Token resistance manipulation
Number of subjects: 100
Study 7653320 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselor alliance
Number of subjects: 41
Study 7653320 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer alliance
Number of subjects: 41
Study 7653320 — intervention group
Group type: EXPERIMENTAL
Intervention: Both counselor and peer alliance
Number of subjects: 41
Study 7653320 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 41
Study 2286600 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical radiotherapy
Number of subjects: 0
Study 2286600 — intervention group
Group type: COMPARATOR
Intervention: Wait-and-see approach (control)
Number of subjects: 0
Study 6169578 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 50
Study 6169578 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 50
Study 31776278 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E
Number of subjects: 0
Study 31776278 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed boosting with AIDSVAX B/E
Number of subjects: 0
Study 29863966 — intervention group
Group type: EXPERIMENTAL
Intervention: False-positive feedback
Number of subjects: 15
Study 29863966 — intervention group
Group type: EXPERIMENTAL
Intervention: False-negative feedback
Number of subjects: 15
Study 29863966 — intervention group
Group type: EXPERIMENTAL
Intervention: False-neutral feedback
Number of subjects: 15
Study 28258636 — intervention group
Group type: EXPERIMENTAL
Intervention: Clip attachments (CR group, n = 15)
Number of subjects: 30
Study 28258636 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilient liner attachments (RR group, n = 15)
Number of subjects: 30
Study 28258636 — intervention group
Group type: COMPARATOR
Intervention: Both groups (CR and RR)
Number of subjects: 30
Study 25821959 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-folic acid supplementation
Number of subjects: 569
Study 25821959 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 569
Study 25821959 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc plus iron-folic acid supplementation
Number of subjects: 569
Study 25821959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 569
Study 23953282 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine plus hyaluronidase (75 IU)
Number of subjects: 40
Study 23953282 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine with epinephrine (placebo)
Number of subjects: 40
Study 21658240 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA/GLA diet
Number of subjects: 115
Study 19450818 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)technetium dimercapto-succinic acid scintigraphy
Number of subjects: 70
Study 19450818 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)technetium dimercapto-succinic acid scintigraphy with parallel hole collimator
Number of subjects: 70
Study 19450818 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)technetium dimercapto-succinic acid scintigraphy with pinhole imaging
Number of subjects: 70
Study 17093998 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy with ILM peeling (ILM group)
Number of subjects: 24
Study 17093998 — intervention group
Group type: COMPARATOR
Intervention: Modified grid laser photocoagulation (laser group)
Number of subjects: 24
Study 17093998 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ILM and laser)
Number of subjects: 24
Study 15019536 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 395
Study 15019536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 395
Study 11284796 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (SIT) with standardized extracts of house-dust mite for 3 years
Number of subjects: 27
Study 9222184 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.10 mg/kg/hr
Number of subjects: 10
Study 9222184 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.40 mg/kg/hr
Number of subjects: 10
Study 9222184 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.60 mg/kg/hr
Number of subjects: 10
Study 9222184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7702801 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous saline load (2 L of 0.9% NaCl over 4 h)
Number of subjects: 22
Study 7702801 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary salt repletion (220 mmol/day NaCl)
Number of subjects: 22
Study 7702801 — intervention group
Group type: COMPARATOR
Intervention: Low-salt diet (20 mmol NaCl) with furosemide (3 x 40 mg, po)
Number of subjects: 22
Study 3138220 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermia plus definitive radiotherapy (60 Gy delivered in 1.8‐2.0 Gy fractions 5 times/week with a boost of 5‐10 Gy through reduced portals to residual tumor; hyperthermia delivered twice weekly for 60 minutes at 43 degrees C)
Number of subjects: 117
Study 31782493 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention
Number of subjects: 117
Study 31782493 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 117
Study 29971593 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (20-160 µg/h, maximum infusion rate of 4 mg/day)
Number of subjects: 617
Study 29971593 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine (4-30 µg/min)
Number of subjects: 617
Study 29971593 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 617
Study 29971593 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 617
Study 27242081 — intervention group
Group type: EXPERIMENTAL
Intervention: CRC screening decision aid
Number of subjects: 262
Study 27242081 — intervention group
Group type: COMPARATOR
Intervention: Food safety video (control)
Number of subjects: 262
Study 25903799 — intervention group
Group type: EXPERIMENTAL
Intervention: TES program for screening and treatment of psychological distress
Number of subjects: 0
Study 25903799 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 25903799 — intervention group
Group type: EXPERIMENTAL
Intervention: TES program
Number of subjects: 0
Study 24119004 — intervention group
Group type: EXPERIMENTAL
Intervention: Older Women (intervention group)
Number of subjects: 260
Study 24119004 — intervention group
Group type: COMPARATOR
Intervention: Younger Women (control group)
Number of subjects: 260
Study 20927506 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryo/Cuff (3 × 10 min twice daily)
Number of subjects: 52
Study 20927506 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 52
Study 20927506 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryo/Cuff
Number of subjects: 52
Study 20927506 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 52
Study 18214724 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine medication trials
Number of subjects: 255
Study 16778696 — intervention group
Group type: EXPERIMENTAL
Intervention: Active conservative treatment (two regimens lasting 8 weeks)
Number of subjects: 181
Study 14575968 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta 300 IU/kg three times weekly
Number of subjects: 351
Study 14575968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study 14575968 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta
Number of subjects: 351
Study 10227414 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass mailing recruitment strategy
Number of subjects: 4736
Study 10227414 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced recruitment coordinators
Number of subjects: 4736
Study 10227414 — intervention group
Group type: EXPERIMENTAL
Intervention: Total time spent on recruitment
Number of subjects: 4736
Study 8726899 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion groups
Number of subjects: 218
Study 8726899 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills training
Number of subjects: 218
Study 8726899 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 218
Study 1655315 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2-laser vaporization
Number of subjects: 50
Study 1655315 — intervention group
Group type: COMPARATOR
Intervention: Routine control
Number of subjects: 50
Study 6870162 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypure
Number of subjects: 38
Study 6870162 — intervention group
Group type: EXPERIMENTAL
Intervention: Varidase
Number of subjects: 38
Study 31976804 — intervention group
Group type: EXPERIMENTAL
Intervention: Hebbian-type stimulation (trainingHebb)
Number of subjects: 20
Study 31976804 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (trainingsham)
Number of subjects: 20